No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Sector Update: Health Care Stocks Softer in Late Afternoon Trading
Sector Update: Health Care
Theratechnologies Seeks FDA Approval for EGRIFTA SV Changes
Theratechnologies 10% Higher as Submits Prior Approval Supplement to FDA For Egrifta SV Distribution
Theratechnologies Receives March 2025 PDUFA Goal Date For Updated Tesamorelin F8 Formulation SBLA
Theratechnologies Brief: Says Received March 2025 PDUFA Goal Date For Updated Tesamorelin F8 Formulation SBLA